These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 12048137)

  • 1. Leukocyte count and vascular function in Type 2 diabetic subjects with treated hypertension.
    Woodman RJ; Watts GF; Puddey IB; Burke V; Mori TA; Hodgson JM; Beilin LJ
    Atherosclerosis; 2002 Jul; 163(1):175-81. PubMed ID: 12048137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Idiopathic venous thrombosis is related to systemic inflammatory response and to increased levels of circulating markers of endothelial dysfunction.
    Jezovnik MK; Poredos P
    Int Angiol; 2010 Jun; 29(3):226-31. PubMed ID: 20502419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased levels of tumour necrosis factor-alpha (TNF-alpha) in patients with Type II diabetes mellitus after myocardial infarction are related to endothelial dysfunction.
    Nyström T; Nygren A; Sjöholm A
    Clin Sci (Lond); 2006 Jun; 110(6):673-81. PubMed ID: 16466346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein B-48 as a determinant of endothelial function in obese subjects with type 2 diabetes mellitus: effect of fenofibrate treatment.
    Chan DC; Wong AT; Yamashita S; Watts GF
    Atherosclerosis; 2012 Apr; 221(2):484-9. PubMed ID: 22341868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Markers of low-grade inflammation and soluble cell adhesion molecules in Chinese patients with coronary artery disease.
    Fang L; Wei H; Mak KH; Xiong Z; Song J; Wang D; Lim YL; Chatterjee S
    Can J Cardiol; 2004 Dec; 20(14):1433-8. PubMed ID: 15614337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-reactive protein and risk factors for peripheral vascular disease in subjects with Type 2 diabetes mellitus.
    Yu HI; Sheu WH; Song YM; Liu HC; Lee WJ; Chen YT
    Diabet Med; 2004 Apr; 21(4):336-41. PubMed ID: 15049935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of flow-mediated dilatation and von Willebrand factor as markers of endothelial cell function in health and in hypertension: relationship to cardiovascular risk and effects of treatment: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
    Felmeden DC; Blann AD; Spencer CG; Beevers DG; Lip GY
    Blood Coagul Fibrinolysis; 2003 Jul; 14(5):425-31. PubMed ID: 12851527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brachial artery reactivity in asymptomatic patients with type 2 diabetes mellitus and microalbuminuria (from the Detection of Ischemia in Asymptomatic Diabetics-brachial artery reactivity study).
    Papaioannou GI; Seip RL; Grey NJ; Katten D; Taylor A; Inzucchi SE; Young LH; Chyun DA; Davey JA; Wackers FJ; Iskandrian AE; Ratner RE; Robinson EC; Carolan S; Engel S; Heller GV
    Am J Cardiol; 2004 Aug; 94(3):294-9. PubMed ID: 15276091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial function in patients with newly diagnosed type 2 diabetes receiving early intensive insulin therapy.
    Tian J; Wang J; Li Y; Villarreal D; Carhart R; Dong Y; Wen Y; Liu K
    Am J Hypertens; 2012 Dec; 25(12):1242-8. PubMed ID: 22895449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute-phase markers of inflammation and glomerular structure in patients with type 2 diabetes.
    Dalla Vestra M; Mussap M; Gallina P; Bruseghin M; Cernigoi AM; Saller A; Plebani M; Fioretto P
    J Am Soc Nephrol; 2005 Mar; 16 Suppl 1():S78-82. PubMed ID: 15938041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired flow mediated dilatation as evidence of endothelial dysfunction in chronic atrial fibrillation: relationship to plasma von Willebrand factor and soluble E-selectin levels.
    Freestone B; Chong AY; Nuttall S; Lip GY
    Thromb Res; 2008; 122(1):85-90. PubMed ID: 17996280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-transferrin-bound iron is associated with biomarkers of oxidative stress, inflammation and endothelial dysfunction in type 2 diabetes.
    Aljwaid H; White DL; Collard KJ; Moody AJ; Pinkney JH
    J Diabetes Complications; 2015; 29(7):943-9. PubMed ID: 26104728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic relations between inflammatory markers and mortality in diabetic patients with non-ST elevation acute coronary syndrome.
    Sanchez PL; Morinigo JL; Pabon P; Martin F; Piedra I; Palacios IF; Martin-Luengo C
    Heart; 2004 Mar; 90(3):264-9. PubMed ID: 14966041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imbalance between Angiotensin II - Angiotensin (1-7) system is associated with vascular endothelial dysfunction and inflammation in type 2 diabetes with newly diagnosed hypertension.
    Srivastava P; Badhwar S; Chandran DS; Jaryal AK; Jyotsna VP; Deepak KK
    Diabetes Metab Syndr; 2019; 13(3):2061-2068. PubMed ID: 31235137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is interleukin-18 correlated with endothelial dysfunction and platelet activation in patients with unstable angina?
    Jurcuţ R; Arsenescu I; Puşcariu T; Uscătescu V; Jurcuţ C; Apetrei E; Ginghină C
    Rom J Intern Med; 2005; 43(3-4):199-209. PubMed ID: 16812980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes.
    Caballero AE; Arora S; Saouaf R; Lim SC; Smakowski P; Park JY; King GL; LoGerfo FW; Horton ES; Veves A
    Diabetes; 1999 Sep; 48(9):1856-62. PubMed ID: 10480619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of ultrasensitive CRP and microalbuminuria as cardiovascular risk markers in type 2 diabetic moroccan patients.
    El Boukhrissi F; Benbella I; Ouleghzal H; Safi S; Bamou Y; Balouch L
    Tunis Med; 2017 Novembre; 95(11):982-987. PubMed ID: 29877557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered bioavailability of epoxyeicosatrienoic acids is associated with conduit artery endothelial dysfunction in type 2 diabetic patients.
    Duflot T; Moreau-Grangé L; Roche C; Iacob M; Wils J; Rémy-Jouet I; Cailleux AF; Leuillier M; Renet S; Li D; Morisseau C; Lamoureux F; Richard V; Prévost G; Joannidès R; Bellien J
    Cardiovasc Diabetol; 2019 Mar; 18(1):35. PubMed ID: 30885203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma concentration of C-reactive protein is increased in type I diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: evidence for chronic inflammation.
    Schalkwijk CG; Poland DC; van Dijk W; Kok A; Emeis JJ; Dräger AM; Doni A; van Hinsbergh VW; Stehouwer CD
    Diabetologia; 1999 Mar; 42(3):351-7. PubMed ID: 10096789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent endothelial dysfunction is related to elevated C-reactive protein (CRP) levels in Type II diabetic patients after acute myocardial infarction.
    Nyström T; Nygren A; Sjöholm A
    Clin Sci (Lond); 2005 Feb; 108(2):121-8. PubMed ID: 15504106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.